Royalty Pharma plc (RPRX)
NASDAQ: RPRX · Real-Time Price · USD
38.39
-0.42 (-1.08%)
At close: Dec 12, 2025, 4:00 PM EST
38.25
-0.14 (-0.35%)
After-hours: Dec 12, 2025, 5:48 PM EST
Royalty Pharma Market Cap
Royalty Pharma has a market cap or net worth of $22.16 billion as of December 12, 2025. Its market cap has increased by 88.43% in one year.
Market Cap
22.16B
Enterprise Value
30.02B
1-Year Change
88.43%
Ranking
Category
Stock Price
$38.39
Market Cap Chart
Since June 16, 2020, Royalty Pharma's market cap has increased from $15.76B to $22.16B, an increase of 40.60%. That is a compound annual growth rate of 6.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 11, 2025 | 16.58B | 46.30% |
| Dec 31, 2024 | 11.33B | -9.30% |
| Dec 29, 2023 | 12.50B | -28.31% |
| Dec 30, 2022 | 17.43B | 1.85% |
| Dec 31, 2021 | 17.12B | -11.89% |
| Dec 31, 2020 | 19.43B | 23.26% |
| Jun 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 903.78B |
| Johnson & Johnson | 505.98B |
| AbbVie | 395.86B |
| UnitedHealth Group | 305.02B |
| AstraZeneca | 282.91B |
| Novartis AG | 256.01B |
| Merck & Co. | 245.75B |
| Novo Nordisk | 223.42B |